News & Updates
Filter by Specialty:

Novel miRNA signature reliably detects lethal pancreatic cancer in the early stages
An exosome-based liquid biopsy showed favourable signals for noninvasive, early detection of pancreatic ductal adenocarcinoma (PDAC) in a prospective study.
Novel miRNA signature reliably detects lethal pancreatic cancer in the early stages
14 Jun 2024
Blood-based CRC screening platform delivers promising performance
An investigational blood-based test performs satisfactorily for the early detection of colorectal cancer (CRC), having met all prespecified primary endpoints in the large PREEMPT CRC trial.
Blood-based CRC screening platform delivers promising performance
13 Jun 2024
Statins may protect against primary sclerosing cholangitis in IBD patients
Patients with inflammatory bowel disease (IBD) who use statins appear to have a substantially reduced risk of primary sclerosing cholangitis (PSC), as shown in a retrospective study.
Statins may protect against primary sclerosing cholangitis in IBD patients
12 Jun 2024
Add-on bispecific antibody may alter treatment landscape of G/GEJ cancer
Adding the PD-1/CTLA-4 bispecific antibody cadonilimab to chemotherapy improves overall survival (OS) and progression-free survival (PFS) in individuals with untreated, HER2-negative, locally advanced or metastatic gastric or gastroesophageal junction (G/GEJ) cancer, including patients with PD-L1–low tumours, according to the interim results of the phase III COMPASSION-15 trial.
Add-on bispecific antibody may alter treatment landscape of G/GEJ cancer
12 Jun 2024
Green kiwi may improve GI symptoms in IBS-C patients
Habitual intake of green kiwifruit may effectively relieve abdominal pain and constipation in adults with constipation-predominant irritable bowel syndrome (IBS-C), findings from a study presented at DDW 2024 suggest.
Green kiwi may improve GI symptoms in IBS-C patients
10 Jun 2024
Bariatric surgery helps improve outcomes in IBD
Bariatric surgery (BS), particularly sleeve gastrectomy, contributes to the improvement of disease-specific outcomes in patients with inflammatory bowel disease (IBD) and obesity, reports a study.